Global Addiction Treatment Market: Industry Analysis and Forecast (2019-2026): By Treatment Type, Drug Type, Treatment Center, Distribution Channel and Region.

Global Addiction Treatment Market was valued US$ XX Bn in 2019 and is expected to reach US$ XX Bn by 2026, at a XX% CAGR of around XX% during a forecast period. Global Addiction Treatment Market To know about the Research Methodology :- Request Free Sample Report Rising anxieties problems across the globe, according to National Survey on Drug Use and Health (NSDUH) in recent year, XX Mn adults were alcoholic, which comprised approximately XX Mn men. According to CDC survey, approximately XX Mn deaths cases are registered due to tobacco use. Therefore, addiction treatment is intended to assistance addicted persons from compulsive seeking. Similarly, addiction treatments are provided in several different settings by using a number of behavioral and pharmacological approaches. For that reason, addiction treatment leads the global market.The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis. The increasing number of addicted people, rising number of drug awareness campaigns, prevention programs, and technological innovations are the factors which support the growth of addiction treatment market. The drug awareness campaigns and associated prevention programs, comprise a rise in patient awareness, lift in treatment-seeking frequency supported by growth in government involvement, and increasing attention on reduction of addiction in numerous countries. The rising in successful treatment of drug abuse with new treatments that prevent deterioration and also control drug cravings. Additionally, increasing in number of treatment centers that collaborate with private recovery amenities is penetrating the market, which helps with the increase of treatment access to a growing population. These factors are contributing in the market growth. The report on global addiction treatment market covers segments such as Treatment Type, Drug Type, Treatment Center, Distribution Channel and Region. The Treatment Type segment includes Alcohol Addiction Treatment, Tobacco / Nicotine Addiction Treatment, Opioid Addiction Treatment, and Other Substance Addiction Treatment. Among the Treatment Type, Tobacco / Nicotine Addiction Treatment is accounted for the largest XX% market share in the global Addiction Treatment market. The Drug Type segment is further sub-segmented into Bupropion, Varenicline, Acamprosate, Disulfiram, Naltrexone, Methadone, Buprenorphine, Nicotine Replacement Products, and Others. Based on Treatment Center, the global Addiction Treatment market is sub-segmented into Outpatient Treatment Centers, Residential Treatment Centers, and Inpatient Treatment Centers. Amongst them Outpatient Treatment Centers is accounted for the largest XX% market share in the global Addiction Treatment market. Based on Distribution Channel, the global Addiction Treatment market is sub-segmented into Hospital Pharmacies, Medical Stores and Others. Amongst them Hospital Pharmacies are accounted for the largest XX% market share in the global Addiction Treatment market. Based on regional segment, the global Addiction Treatment market is sub-segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. On the basis of geography, North America, in 2018 represented a dominating share of the total addiction treatment market. This is because of rise in the number of smokers in the U.S. has increased concerns with respect health concerns for the passive smokers as well as active smokers. Asia Pacific market is expected to increase drive in forecasted period. Activities by regional governments to accomplish individuality in production of pharmaceuticals and other encouragements about the production of generics in the nations, for example, South Africa, Saudi Arabia, and Brazil are going to backing the Middle East and Africa and Latin America market. Key players operating in the Addiction Treatment market are Pfizer Inc., Alkermes Plc, GlaxoSmithKline Plc., Purdue Pharma LP, Allergan, Mylan Laboratories, Reckitt Benckiser Pharmaceuticals, Teva Pharmaceuticals, Forest Laboratories, Inc., Accord Healthcare, mphastar Pharmaceuticals, Apotex, BioCorRx, Cipla, Glenmark, INSYS Therapeutics, LFB Group, Lupin, Opiant Technologies, Sanofi Aventis, Sanquin, Sterinova, Sun Pharmaceuticals. Addiction treatment providers and manufacturers of treatment products are concentrating on increasing consciousness amongst people and drug store owners about adverse effects of drug abuse and significance of abuse treatment to upsurge the customer pool. Furthermore, companies are proposing training for identification of potential drug abusers and alcohol abusers and usage of drug abuse testing to law implementation organizations. Awareness through television advertisements, newspapers, information brochures, and other media have demonstrated to be effective in restriction substance abuse crisis. Noteworthy pipeline and emphasis on research and development are the key strategies employ by leading players to boost their market occurrence. This is expected to fortify the growth of the global Addiction Treatment market. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding global Addiction Treatment market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by Product, price, financial position, Product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address the question of shareholders to prioritizing the efforts and investment shortly to the emerging segment in the global Addiction Treatment market.

Scope of the Global Addiction Treatment Market: Inquire before buying

Global Addiction Treatment Market, By Treatment Type

• Alcohol Addiction Treatment • Tobacco / Nicotine Addiction Treatment • Opioid Addiction Treatment • Other Substance Addiction Treatment

Global Addiction Treatment Market, By Drug Type

• Bupropion • Varenicline • Acamprosate • Disulfiram • Naltrexone • Methadone • Buprenorphine • Nicotine replacement products • Others surgical

Global Addiction Treatment Market, By Treatment Center

• Outpatient Treatment Centers • Residential Treatment Centers • Inpatient Treatment Centers

Global Addiction Treatment Market, By Distribution Channel

• Hospital Pharmacies • Medical Stores • Others

Global Addiction Treatment Market, By Region

• North America • Europe • Asia Pacific • Middle East & Africa • South America

Key players operating in the Global Addiction Treatment Market

• Pfizer Inc. • Alkermes Plc. • GlaxoSmithKline Plc. • Purdue Pharma LP. • Allergan • Mylan Laboratories • Reckitt Benckiser Pharmaceuticals • Teva Pharmaceuticals • Forest Laboratories, Inc. • Accord Healthcare • mphastar Pharmaceuticals • Apotex • BioCorRx • Cipla • Glenmark • INSYS Therapeutics • LFB Group • Lupin • Opiant Technologies • Sanofi Aventis • Sanquin • Sterinova • Sun Pharmaceuticals
Global Addiction Treatment Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Addiction Treatment Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Addiction Treatment Market Analysis and Forecast 6.1. Global Addiction Treatment Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Addiction Treatment Market Analysis and Forecast, By Treatment Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Addiction Treatment Market Value Share Analysis, By Treatment Type 7.4. Global Addiction Treatment Market Size (US$ Bn) Forecast, By Treatment Type 7.5. Global Addiction Treatment Market Analysis, By Treatment Type 7.6. Global Addiction Treatment Market Attractiveness Analysis, By Treatment Type 8. Global Addiction Treatment Market Analysis and Forecast, By Drug Type 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Addiction Treatment Market Value Share Analysis, By Drug Type 8.4. Global Addiction Treatment Market Size (US$ Bn) Forecast, By Drug Type 8.5. Global Addiction Treatment Market Analysis, By Drug Type 8.6. Global Addiction Treatment Market Attractiveness Analysis, By Drug Type 9. Global Addiction Treatment Market Analysis and Forecast, By Treatment Center 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Addiction Treatment Market Value Share Analysis, By Treatment Center 9.4. Global Addiction Treatment Market Size (US$ Bn) Forecast, By Treatment Center 9.5. Global Addiction Treatment Market Analysis, By Treatment Center 9.6. Global Addiction Treatment Market Attractiveness Analysis, By Treatment Center 10. Global Addiction Treatment Market Analysis and Forecast, By Distribution Channel 10.1. Introduction and Definition 10.2. Key Findings 10.3. Global Addiction Treatment Market Value Share Analysis, By Distribution Channel 10.4. Global Addiction Treatment Market Size (US$ Bn) Forecast, By Distribution Channel 10.5. Global Addiction Treatment Market Analysis, By Distribution Channel 10.6. Global Addiction Treatment Market Attractiveness Analysis, By Distribution Channel 11. Global Addiction Treatment Market Analysis, by Region 11.1. Global Addiction Treatment Market Value Share Analysis, by Region 11.2. Global Addiction Treatment Market Size (US$ Bn) Forecast, by Region 11.3. Global Addiction Treatment Market Attractiveness Analysis, by Region 12. North America Addiction Treatment Market Analysis 12.1. Key Findings 12.2. North America Addiction Treatment Market Overview 12.3. North America Addiction Treatment Market Value Share Analysis, By Treatment Type 12.4. North America Addiction Treatment Market Forecast, By Treatment Type 12.4.1. Alcohol Addiction Treatment 12.4.2. Tobacco / Nicotine Addiction Treatment 12.4.3. Opioid Addiction Treatment 12.4.4. Other Substance Addiction Treatment 12.5. North America Addiction Treatment Market Value Share Analysis, By Drug Type 12.6. North America Addiction Treatment Market Forecast, By Drug Type 12.6.1. Bupropion 12.6.2. Varenicline 12.6.3. Acamprosate 12.6.4. Disulfiram 12.6.5. Naltrexone 12.6.6. Methadone 12.6.7. Buprenorphine 12.6.8. Nicotine replacement products 12.6.9. Others surgical 12.7. North America Addiction Treatment Market Value Share Analysis, By Treatment Center 12.8. North America Addiction Treatment Market Forecast, By Treatment Center 12.8.1. Outpatient Treatment Centers 12.8.2. Residential Treatment Centers 12.8.3. Inpatient Treatment Centers 12.9. North America Addiction Treatment Market Value Share Analysis, By Distribution Channel 12.10. North America Addiction Treatment Market Forecast, By Distribution Channel 12.10.1. Hospital Pharmacies 12.10.2. Medical Stores 12.10.3. Others 12.11. North America Addiction Treatment Market Value Share Analysis, by Country 12.12. North America Addiction Treatment Market Forecast, by Country 12.12.1. U.S. 12.12.2. Canada 12.13. North America Addiction Treatment Market Analysis, by Country 12.14. U.S. Addiction Treatment Market Forecast, By Treatment Type 12.14.1. Alcohol Addiction Treatment 12.14.2. Tobacco / Nicotine Addiction Treatment 12.14.3. Opioid Addiction Treatment 12.14.4. Other Substance Addiction Treatment 12.15. U.S. Addiction Treatment Market Forecast, By Drug Type 12.15.1. Bupropion 12.15.2. Varenicline 12.15.3. Acamprosate 12.15.4. Disulfiram 12.15.5. Naltrexone 12.15.6. Methadone 12.15.7. Buprenorphine 12.15.8. Nicotine replacement products 12.15.9. Others surgical 12.16. U.S. Addiction Treatment Market Forecast, By Treatment Center 12.16.1. Outpatient Treatment Centers 12.16.2. Residential Treatment Centers 12.16.3. Inpatient Treatment Centers 12.17. U.S. Addiction Treatment Market Forecast, By Distribution Channel 12.17.1. Hospital Pharmacies 12.17.2. Medical Stores 12.17.3. Others 12.18. Canada Addiction Treatment Market Forecast, By Treatment Type 12.18.1. Alcohol Addiction Treatment 12.18.2. Tobacco / Nicotine Addiction Treatment 12.18.3. Opioid Addiction Treatment 12.18.4. Other Substance Addiction Treatment 12.19. Canada Addiction Treatment Market Forecast, By Drug Type 12.19.1. Bupropion 12.19.2. Varenicline 12.19.3. Acamprosate 12.19.4. Disulfiram 12.19.5. Naltrexone 12.19.6. Methadone 12.19.7. Buprenorphine 12.19.8. Nicotine replacement products 12.19.9. Others surgical 12.20. Canada Addiction Treatment Market Forecast, By Treatment Center 12.20.1. Outpatient Treatment Centers 12.20.2. Residential Treatment Centers 12.20.3. Inpatient Treatment Centers 12.21. Canada Addiction Treatment Market Forecast, By Distribution Channel 12.21.1. Hospital Pharmacies 12.21.2. Medical Stores 12.21.3. Others 12.22. North America Addiction Treatment Market Attractiveness Analysis 12.22.1. By Treatment Type 12.22.2. By Drug Type 12.22.3. By Treatment Center 12.22.4. By Distribution Channel 12.23. PEST Analysis 12.24. Key Trends 12.25. Key Developments 13. Europe Addiction Treatment Market Analysis 13.1. Key Findings 13.2. Europe Addiction Treatment Market Overview 13.3. Europe Addiction Treatment Market Value Share Analysis, By Treatment Type 13.4. Europe Addiction Treatment Market Forecast, By Treatment Type 13.4.1. Alcohol Addiction Treatment 13.4.2. Tobacco / Nicotine Addiction Treatment 13.4.3. Opioid Addiction Treatment 13.4.4. Other Substance Addiction Treatment 13.5. Europe Addiction Treatment Market Value Share Analysis, By Drug Type 13.6. Europe Addiction Treatment Market Forecast, By Drug Type 13.6.1. Bupropion 13.6.2. Varenicline 13.6.3. Acamprosate 13.6.4. Disulfiram 13.6.5. Naltrexone 13.6.6. Methadone 13.6.7. Buprenorphine 13.6.8. Nicotine replacement products 13.6.9. Others surgical 13.7. Europe Addiction Treatment Market Value Share Analysis, By Treatment Center 13.8. Europe Addiction Treatment Market Forecast, By Treatment Center 13.8.1. Outpatient Treatment Centers 13.8.2. Residential Treatment Centers 13.8.3. Inpatient Treatment Centers 13.9. Europe Addiction Treatment Market Value Share Analysis, By Distribution Channel 13.10. Europe Addiction Treatment Market Forecast, By Distribution Channel 13.10.1. Hospital Pharmacies 13.10.2. Medical Stores 13.10.3. Others 13.11. Europe Addiction Treatment Market Value Share Analysis, by Country 13.12. Europe Addiction Treatment Market Forecast, by Country 13.12.1. Germany 13.12.2. U.K. 13.12.3. France 13.12.4. Italy 13.12.5. Spain 13.12.6. Rest of Europe 13.13. Europe Addiction Treatment Market Analysis, by Country 13.14. Germany Addiction Treatment Market Forecast, By Treatment Type 13.14.1. Alcohol Addiction Treatment 13.14.2. Tobacco / Nicotine Addiction Treatment 13.14.3. Opioid Addiction Treatment 13.14.4. Other Substance Addiction Treatment 13.15. Germany Addiction Treatment Market Forecast, By Drug Type 13.15.1. Bupropion 13.15.2. Varenicline 13.15.3. Acamprosate 13.15.4. Disulfiram 13.15.5. Naltrexone 13.15.6. Methadone 13.15.7. Buprenorphine 13.15.8. Nicotine replacement products 13.15.9. Others surgical 13.16. Germany Addiction Treatment Market Forecast, By Treatment Center 13.16.1. Outpatient Treatment Centers 13.16.2. Residential Treatment Centers 13.16.3. Inpatient Treatment Centers 13.17. Germany Addiction Treatment Market Forecast, By Distribution Channel 13.17.1. Hospital Pharmacies 13.17.2. Medical Stores 13.17.3. Others 13.18. U.K. Addiction Treatment Market Forecast, By Treatment Type 13.18.1. Alcohol Addiction Treatment 13.18.2. Tobacco / Nicotine Addiction Treatment 13.18.3. Opioid Addiction Treatment 13.18.4. Other Substance Addiction Treatment 13.19. U.K. Addiction Treatment Market Forecast, By Drug Type 13.19.1. Bupropion 13.19.2. Varenicline 13.19.3. Acamprosate 13.19.4. Disulfiram 13.19.5. Naltrexone 13.19.6. Methadone 13.19.7. Buprenorphine 13.19.8. Nicotine replacement products 13.19.9. Others surgical 13.20. U.K. Addiction Treatment Market Forecast, By Treatment Center 13.20.1. Outpatient Treatment Centers 13.20.2. Residential Treatment Centers 13.20.3. Inpatient Treatment Centers 13.21. U.K. Addiction Treatment Market Forecast, By Distribution Channel 13.21.1. Hospital Pharmacies 13.21.2. Medical Stores 13.21.3. Others 13.22. France Addiction Treatment Market Forecast, By Treatment Type 13.22.1. Alcohol Addiction Treatment 13.22.2. Tobacco / Nicotine Addiction Treatment 13.22.3. Opioid Addiction Treatment 13.22.4. Other Substance Addiction Treatment 13.23. France Addiction Treatment Market Forecast, By Drug Type 13.23.1. Bupropion 13.23.2. Varenicline 13.23.3. Acamprosate 13.23.4. Disulfiram 13.23.5. Naltrexone 13.23.6. Methadone 13.23.7. Buprenorphine 13.23.8. Nicotine replacement products 13.23.9. Others surgical 13.24. France Addiction Treatment Market Forecast, By Treatment Center 13.24.1. Outpatient Treatment Centers 13.24.2. Residential Treatment Centers 13.24.3. Inpatient Treatment Centers 13.25. France Addiction Treatment Market Forecast, By Distribution Channel 13.25.1. Hospital Pharmacies 13.25.2. Medical Stores 13.25.3. Others 13.26. Italy Addiction Treatment Market Forecast, By Treatment Type 13.26.1. Alcohol Addiction Treatment 13.26.2. Tobacco / Nicotine Addiction Treatment 13.26.3. Opioid Addiction Treatment 13.26.4. Other Substance Addiction Treatment 13.27. Italy Addiction Treatment Market Forecast, By Drug Type 13.27.1. Bupropion 13.27.2. Varenicline 13.27.3. Acamprosate 13.27.4. Disulfiram 13.27.5. Naltrexone 13.27.6. Methadone 13.27.7. Buprenorphine 13.27.8. Nicotine replacement products 13.27.9. Others surgical 13.28. Italy Addiction Treatment Market Forecast, By Treatment Center 13.28.1. Outpatient Treatment Centers 13.28.2. Residential Treatment Centers 13.28.3. Inpatient Treatment Centers 13.29. Italy Addiction Treatment Market Forecast, By Distribution Channel 13.29.1. Hospital Pharmacies 13.29.2. Medical Stores 13.29.3. Others 13.30. Spain Addiction Treatment Market Forecast, By Treatment Type 13.30.1. Alcohol Addiction Treatment 13.30.2. Tobacco / Nicotine Addiction Treatment 13.30.3. Opioid Addiction Treatment 13.30.4. Other Substance Addiction Treatment 13.31. Spain Addiction Treatment Market Forecast, By Drug Type 13.31.1. Bupropion 13.31.2. Varenicline 13.31.3. Acamprosate 13.31.4. Disulfiram 13.31.5. Naltrexone 13.31.6. Methadone 13.31.7. Buprenorphine 13.31.8. Nicotine replacement products 13.31.9. Others surgical 13.32. Spain Addiction Treatment Market Forecast, By Treatment Center 13.32.1. Outpatient Treatment Centers 13.32.2. Residential Treatment Centers 13.32.3. Inpatient Treatment Centers 13.33. Spain Addiction Treatment Market Forecast, By Distribution Channel 13.33.1. Hospital Pharmacies 13.33.2. Medical Stores 13.33.3. Others 13.34. Rest of Europe Addiction Treatment Market Forecast, By Treatment Type 13.34.1. Alcohol Addiction Treatment 13.34.2. Tobacco / Nicotine Addiction Treatment 13.34.3. Opioid Addiction Treatment 13.34.4. Other Substance Addiction Treatment 13.35. Rest of Europe Addiction Treatment Market Forecast, By Drug Type 13.35.1. Bupropion 13.35.2. Varenicline 13.35.3. Acamprosate 13.35.4. Disulfiram 13.35.5. Naltrexone 13.35.6. Methadone 13.35.7. Buprenorphine 13.35.8. Nicotine replacement products 13.35.9. Others surgical 13.36. Rest of Europe Addiction Treatment Market Forecast, By Treatment Center 13.36.1. Outpatient Treatment Centers 13.36.2. Residential Treatment Centers 13.36.3. Inpatient Treatment Centers 13.37. Rest of Europe Addiction Treatment Market Forecast, By Distribution Channel 13.37.1. Hospital Pharmacies 13.37.2. Medical Stores 13.37.3. Others 13.38. Europe Addiction Treatment Market Attractiveness Analysis 13.38.1. By Treatment Type 13.38.2. By Drug Type 13.38.3. By Treatment Center 13.38.4. By Distribution Channel 13.39. PEST Analysis 13.40. Key Trends 13.41. Key Developments 14. Asia Pacific Addiction Treatment Market Analysis 14.1. Key Findings 14.2. Asia Pacific Addiction Treatment Market Overview 14.3. Asia Pacific Addiction Treatment Market Value Share Analysis, By Treatment Type 14.4. Asia Pacific Addiction Treatment Market Forecast, By Treatment Type 14.4.1. Alcohol Addiction Treatment 14.4.2. Tobacco / Nicotine Addiction Treatment 14.4.3. Opioid Addiction Treatment 14.4.4. Other Substance Addiction Treatment 14.5. Asia Pacific Addiction Treatment Market Value Share Analysis, By Drug Type 14.6. Asia Pacific Addiction Treatment Market Forecast, By Drug Type 14.6.1. Bupropion 14.6.2. Varenicline 14.6.3. Acamprosate 14.6.4. Disulfiram 14.6.5. Naltrexone 14.6.6. Methadone 14.6.7. Buprenorphine 14.6.8. Nicotine replacement products 14.6.9. Others surgical 14.7. Asia Pacific Addiction Treatment Market Value Share Analysis, By Treatment Center 14.8. Asia Pacific Addiction Treatment Market Forecast, By Treatment Center 14.8.1. Outpatient Treatment Centers 14.8.2. Residential Treatment Centers 14.8.3. Inpatient Treatment Centers 14.9. Asia Pacific Addiction Treatment Market Value Share Analysis, By Distribution Channel 14.10. Asia Pacific Addiction Treatment Market Forecast, By Distribution Channel 14.10.1. Hospital Pharmacies 14.10.2. Medical Stores 14.10.3. Others 14.11. Asia Pacific Addiction Treatment Market Value Share Analysis, by Country 14.12. Asia Pacific Addiction Treatment Market Forecast, by Country 14.12.1. China 14.12.2. India 14.12.3. Japan 14.12.4. ASEAN 14.12.5. Rest of Asia Pacific 14.13. Asia Pacific Addiction Treatment Market Analysis, by Country 14.14. China Addiction Treatment Market Forecast, By Treatment Type 14.14.1. Alcohol Addiction Treatment 14.14.2. Tobacco / Nicotine Addiction Treatment 14.14.3. Opioid Addiction Treatment 14.14.4. Other Substance Addiction Treatment 14.15. China Addiction Treatment Market Forecast, By Drug Type 14.15.1. Bupropion 14.15.2. Varenicline 14.15.3. Acamprosate 14.15.4. Disulfiram 14.15.5. Naltrexone 14.15.6. Methadone 14.15.7. Buprenorphine 14.15.8. Nicotine replacement products 14.15.9. Others surgical 14.16. China Addiction Treatment Market Forecast, By Treatment Center 14.16.1. Outpatient Treatment Centers 14.16.2. Residential Treatment Centers 14.16.3. Inpatient Treatment Centers 14.17. China Addiction Treatment Market Forecast, By Distribution Channel 14.17.1. Hospital Pharmacies 14.17.2. Medical Stores 14.17.3. Others 14.18. India Addiction Treatment Market Forecast, By Treatment Type 14.18.1. Alcohol Addiction Treatment 14.18.2. Tobacco / Nicotine Addiction Treatment 14.18.3. Opioid Addiction Treatment 14.18.4. Other Substance Addiction Treatment 14.19. India Addiction Treatment Market Forecast, By Drug Type 14.19.1. Bupropion 14.19.2. Varenicline 14.19.3. Acamprosate 14.19.4. Disulfiram 14.19.5. Naltrexone 14.19.6. Methadone 14.19.7. Buprenorphine 14.19.8. Nicotine replacement products 14.19.9. Others surgical 14.20. India Addiction Treatment Market Forecast, By Treatment Center 14.20.1. Outpatient Treatment Centers 14.20.2. Residential Treatment Centers 14.20.3. Inpatient Treatment Centers 14.21. India Addiction Treatment Market Forecast, By Distribution Channel 14.21.1. Hospital Pharmacies 14.21.2. Medical Stores 14.21.3. Others 14.22. Japan Addiction Treatment Market Forecast, By Treatment Type 14.22.1. Alcohol Addiction Treatment 14.22.2. Tobacco / Nicotine Addiction Treatment 14.22.3. Opioid Addiction Treatment 14.22.4. Other Substance Addiction Treatment 14.23. Japan Addiction Treatment Market Forecast, By Drug Type 14.23.1. Bupropion 14.23.2. Varenicline 14.23.3. Acamprosate 14.23.4. Disulfiram 14.23.5. Naltrexone 14.23.6. Methadone 14.23.7. Buprenorphine 14.23.8. Nicotine replacement products 14.23.9. Others surgical 14.24. Japan Addiction Treatment Market Forecast, By Treatment Center 14.24.1. Outpatient Treatment Centers 14.24.2. Residential Treatment Centers 14.24.3. Inpatient Treatment Centers 14.25. Japan Addiction Treatment Market Forecast, By Distribution Channel 14.25.1. Hospital Pharmacies 14.25.2. Medical Stores 14.25.3. Others 14.26. ASEAN Addiction Treatment Market Forecast, By Treatment Type 14.26.1. Alcohol Addiction Treatment 14.26.2. Tobacco / Nicotine Addiction Treatment 14.26.3. Opioid Addiction Treatment 14.26.4. Other Substance Addiction Treatment 14.27. ASEAN Addiction Treatment Market Forecast, By Drug Type 14.27.1. Bupropion 14.27.2. Varenicline 14.27.3. Acamprosate 14.27.4. Disulfiram 14.27.5. Naltrexone 14.27.6. Methadone 14.27.7. Buprenorphine 14.27.8. Nicotine replacement products 14.27.9. Others surgical 14.28. ASEAN Addiction Treatment Market Forecast, By Treatment Center 14.28.1. Outpatient Treatment Centers 14.28.2. Residential Treatment Centers 14.28.3. Inpatient Treatment Centers 14.29. ASEAN Addiction Treatment Market Forecast, By Distribution Channel 14.29.1. Hospital Pharmacies 14.29.2. Medical Stores 14.29.3. Others 14.30. Rest of Asia Pacific Addiction Treatment Market Forecast, By Treatment Type 14.30.1. Alcohol Addiction Treatment 14.30.2. Tobacco / Nicotine Addiction Treatment 14.30.3. Opioid Addiction Treatment 14.30.4. Other Substance Addiction Treatment 14.31. Rest of Asia Pacific Addiction Treatment Market Forecast, By Drug Type 14.31.1. Bupropion 14.31.2. Varenicline 14.31.3. Acamprosate 14.31.4. Disulfiram 14.31.5. Naltrexone 14.31.6. Methadone 14.31.7. Buprenorphine 14.31.8. Nicotine replacement products 14.31.9. Others surgical 14.32. Rest of Asia Pacific Addiction Treatment Market Forecast, By Treatment Center 14.32.1. Outpatient Treatment Centers 14.32.2. Residential Treatment Centers 14.32.3. Inpatient Treatment Centers 14.33. Rest of Asia Pacific Addiction Treatment Market Forecast, By Distribution Channel 14.33.1. Hospital Pharmacies 14.33.2. Medical Stores 14.33.3. Others 14.34. Asia Pacific Addiction Treatment Market Attractiveness Analysis 14.34.1. By Treatment Type 14.34.2. By Drug Type 14.34.3. By Treatment Center 14.34.4. By Distribution Channel 14.35. PEST Analysis 14.36. Key Trends 14.37. Key Developments 15. Middle East & Africa Addiction Treatment Market Analysis 15.1. Key Findings 15.2. Middle East & Africa Addiction Treatment Market Overview 15.3. Middle East & Africa Addiction Treatment Market Value Share Analysis, By Treatment Type 15.4. Middle East & Africa Addiction Treatment Market Forecast, By Treatment Type 15.4.1. Alcohol Addiction Treatment 15.4.2. Tobacco / Nicotine Addiction Treatment 15.4.3. Opioid Addiction Treatment 15.4.4. Other Substance Addiction Treatment 15.5. Middle East & Africa Addiction Treatment Market Value Share Analysis, By Drug Type 15.6. Middle East & Africa Addiction Treatment Market Forecast, By Drug Type 15.6.1. Bupropion 15.6.2. Varenicline 15.6.3. Acamprosate 15.6.4. Disulfiram 15.6.5. Naltrexone 15.6.6. Methadone 15.6.7. Buprenorphine 15.6.8. Nicotine replacement products 15.6.9. Others surgical 15.7. Middle East & Africa Addiction Treatment Market Value Share Analysis, By Treatment Center 15.8. Middle East & Africa Addiction Treatment Market Forecast, By Treatment Center 15.8.1. Outpatient Treatment Centers 15.8.2. Residential Treatment Centers 15.8.3. Inpatient Treatment Centers 15.9. Middle East & Africa Addiction Treatment Market Value Share Analysis, By Distribution Channel 15.10. Middle East & Africa Addiction Treatment Market Forecast, By Distribution Channel 15.10.1. Hospital Pharmacies 15.10.2. Medical Stores 15.10.3. Others 15.11. Middle East & Africa Addiction Treatment Market Value Share Analysis, by Country 15.12. Middle East & Africa Addiction Treatment Market Forecast, by Country 15.12.1. GCC 15.12.2. South Africa 15.12.3. Rest of Middle East & Africa 15.13. Middle East & Africa Addiction Treatment Market Analysis, by Country 15.14. GCC Addiction Treatment Market Forecast, By Treatment Type 15.14.1. Alcohol Addiction Treatment 15.14.2. Tobacco / Nicotine Addiction Treatment 15.14.3. Opioid Addiction Treatment 15.14.4. Other Substance Addiction Treatment 15.15. GCC Addiction Treatment Market Forecast, By Drug Type 15.15.1. Bupropion 15.15.2. Varenicline 15.15.3. Acamprosate 15.15.4. Disulfiram 15.15.5. Naltrexone 15.15.6. Methadone 15.15.7. Buprenorphine 15.15.8. Nicotine replacement products 15.15.9. Others surgical 15.16. GCC Addiction Treatment Market Forecast, By Treatment Center 15.16.1. Outpatient Treatment Centers 15.16.2. Residential Treatment Centers 15.16.3. Inpatient Treatment Centers 15.17. GCC Addiction Treatment Market Forecast, By Distribution Channel 15.17.1. Hospital Pharmacies 15.17.2. Medical Stores 15.17.3. Others 15.18. South Africa Addiction Treatment Market Forecast, By Treatment Type 15.18.1. Alcohol Addiction Treatment 15.18.2. Tobacco / Nicotine Addiction Treatment 15.18.3. Opioid Addiction Treatment 15.18.4. Other Substance Addiction Treatment 15.19. South Africa Addiction Treatment Market Forecast, By Drug Type 15.19.1. Bupropion 15.19.2. Varenicline 15.19.3. Acamprosate 15.19.4. Disulfiram 15.19.5. Naltrexone 15.19.6. Methadone 15.19.7. Buprenorphine 15.19.8. Nicotine replacement products 15.19.9. Others surgical 15.20. South Africa Addiction Treatment Market Forecast, By Treatment Center 15.20.1. Outpatient Treatment Centers 15.20.2. Residential Treatment Centers 15.20.3. Inpatient Treatment Centers 15.21. South Africa Addiction Treatment Market Forecast, By Distribution Channel 15.21.1. Hospital Pharmacies 15.21.2. Medical Stores 15.21.3. Others 15.22. Rest of Middle East & Africa Addiction Treatment Market Forecast, By Treatment Type 15.22.1. Alcohol Addiction Treatment 15.22.2. Tobacco / Nicotine Addiction Treatment 15.22.3. Opioid Addiction Treatment 15.22.4. Other Substance Addiction Treatment 15.23. Rest of Middle East & Africa Addiction Treatment Market Forecast, By Drug Type 15.23.1. Bupropion 15.23.2. Varenicline 15.23.3. Acamprosate 15.23.4. Disulfiram 15.23.5. Naltrexone 15.23.6. Methadone 15.23.7. Buprenorphine 15.23.8. Nicotine replacement products 15.23.9. Others surgical 15.24. Rest of Middle East & Africa Addiction Treatment Market Forecast, By Treatment Center 15.24.1. Outpatient Treatment Centers 15.24.2. Residential Treatment Centers 15.24.3. Inpatient Treatment Centers 15.25. Rest of Middle East & Africa Addiction Treatment Market Forecast, By Distribution Channel 15.25.1. Hospital Pharmacies 15.25.2. Medical Stores 15.25.3. Others 15.26. Middle East & Africa Addiction Treatment Market Attractiveness Analysis 15.26.1. By Treatment Type 15.26.2. By Drug Type 15.26.3. By Treatment Center 15.26.4. By Distribution Channel 15.27. PEST Analysis 15.28. Key Trends 15.29. Key Developments 16. South America Addiction Treatment Market Analysis 16.1. Key Findings 16.2. South America Addiction Treatment Market Overview 16.3. South America Addiction Treatment Market Value Share Analysis, By Treatment Type 16.4. South America Addiction Treatment Market Forecast, By Treatment Type 16.4.1. Alcohol Addiction Treatment 16.4.2. Tobacco / Nicotine Addiction Treatment 16.4.3. Opioid Addiction Treatment 16.4.4. Other Substance Addiction Treatment 16.5. South America Addiction Treatment Market Value Share Analysis, By Drug Type 16.6. South America Addiction Treatment Market Forecast, By Drug Type 16.6.1. Bupropion 16.6.2. Varenicline 16.6.3. Acamprosate 16.6.4. Disulfiram 16.6.5. Naltrexone 16.6.6. Methadone 16.6.7. Buprenorphine 16.6.8. Nicotine replacement products 16.6.9. Others surgical 16.7. South America Addiction Treatment Market Value Share Analysis, By Treatment Center 16.8. South America Addiction Treatment Market Forecast, By Treatment Center 16.8.1. Outpatient Treatment Centers 16.8.2. Residential Treatment Centers 16.8.3. Inpatient Treatment Centers 16.9. South America Addiction Treatment Market Value Share Analysis, By Distribution Channel 16.10. South America Addiction Treatment Market Forecast, By Distribution Channel 16.10.1. Hospital Pharmacies 16.10.2. Medical Stores 16.10.3. Others 16.11. South America Addiction Treatment Market Value Share Analysis, by Country 16.12. South America Addiction Treatment Market Forecast, by Country 16.12.1. Brazil 16.12.2. Mexico 16.12.3. Rest of South America 16.13. South America Addiction Treatment Market Analysis, by Country 16.14. Brazil Addiction Treatment Market Forecast, By Treatment Type 16.14.1. Alcohol Addiction Treatment 16.14.2. Tobacco / Nicotine Addiction Treatment 16.14.3. Opioid Addiction Treatment 16.14.4. Other Substance Addiction Treatment 16.15. Brazil Addiction Treatment Market Forecast, By Drug Type 16.15.1. Bupropion 16.15.2. Varenicline 16.15.3. Acamprosate 16.15.4. Disulfiram 16.15.5. Naltrexone 16.15.6. Methadone 16.15.7. Buprenorphine 16.15.8. Nicotine replacement products 16.15.9. Others surgical 16.16. Brazil Addiction Treatment Market Forecast, By Treatment Center 16.16.1. Outpatient Treatment Centers 16.16.2. Residential Treatment Centers 16.16.3. Inpatient Treatment Centers 16.17. Brazil Addiction Treatment Market Forecast, By Distribution Channel 16.17.1. Hospital Pharmacies 16.17.2. Medical Stores 16.17.3. Others 16.18. Mexico Addiction Treatment Market Forecast, By Treatment Type 16.18.1. Alcohol Addiction Treatment 16.18.2. Tobacco / Nicotine Addiction Treatment 16.18.3. Opioid Addiction Treatment 16.18.4. Other Substance Addiction Treatment 16.19. Mexico Addiction Treatment Market Forecast, By Drug Type 16.19.1. Bupropion 16.19.2. Varenicline 16.19.3. Acamprosate 16.19.4. Disulfiram 16.19.5. Naltrexone 16.19.6. Methadone 16.19.7. Buprenorphine 16.19.8. Nicotine replacement products 16.19.9. Others surgical 16.20. Mexico Addiction Treatment Market Forecast, By Treatment Center 16.20.1. Outpatient Treatment Centers 16.20.2. Residential Treatment Centers 16.20.3. Inpatient Treatment Centers 16.21. Mexico Addiction Treatment Market Forecast, By Distribution Channel 16.21.1. Hospital Pharmacies 16.21.2. Medical Stores 16.21.3. Others 16.22. Rest of South America Addiction Treatment Market Forecast, By Treatment Type 16.22.1. Alcohol Addiction Treatment 16.22.2. Tobacco / Nicotine Addiction Treatment 16.22.3. Opioid Addiction Treatment 16.22.4. Other Substance Addiction Treatment 16.23. Rest of South America Addiction Treatment Market Forecast, By Drug Type 16.23.1. Bupropion 16.23.2. Varenicline 16.23.3. Acamprosate 16.23.4. Disulfiram 16.23.5. Naltrexone 16.23.6. Methadone 16.23.7. Buprenorphine 16.23.8. Nicotine replacement products 16.23.9. Others surgical 16.24. Rest of South America Addiction Treatment Market Forecast, By Treatment Center 16.24.1. Outpatient Treatment Centers 16.24.2. Residential Treatment Centers 16.24.3. Inpatient Treatment Centers 16.25. Rest of South America Addiction Treatment Market Forecast, By Distribution Channel 16.25.1. Hospital Pharmacies 16.25.2. Medical Stores 16.25.3. Others 16.26. South America Addiction Treatment Market Attractiveness Analysis 16.26.1. By Treatment Type 16.26.2. By Drug Type 16.26.3. By Treatment Center 16.26.4. By Distribution Channel 16.27. PEST Analysis 16.28. Key Trends 16.29. Key Developments 17. Company Profiles 17.1. Market Share Analysis, by Company 17.2. Competition Matrix 17.2.1. Competitive Benchmarking of key players by price, presence, market share, Drug Types and R&D investment 17.2.2. New Treatment Center Launches and Treatment Center Enhancements 17.2.3. Market Consolidation 17.2.3.1. M&A by Regions, Investment and Drug Types 17.2.3.2. M&A Key Players, Forward Integration and Backward Integration 17.3. Company Profiles: Key Players 17.3.1. Pfizer 17.3.1.1. Company Overview 17.3.1.2. Financial Overview 17.3.1.3. Treatment Center Portfolio 17.3.1.4. Business Strategy 17.3.1.5. Recent Developments 17.3.1.6. Company Footprint 17.3.2. Alkermes Plc. 17.3.3. GlaxoSmithKline Plc. 17.3.4. Purdue Pharma LP. 17.3.5. Allergan 17.3.6. Mylan Laboratories 17.3.7. Reckitt Benckiser Pharmaceuticals 17.3.8. Teva Pharmaceuticals 17.3.9. Forest Laboratories, Inc. 17.3.10. Accord Healthcare 17.3.11. mphastar Pharmaceuticals 17.3.12. Apotex 17.3.13. BioCorRx 17.3.14. Cipla 17.3.15. Glenmark 17.3.16. INSYS Therapeutics 17.3.17. LFB Group 17.3.18. Lupin 17.3.19. Opiant Technologies 17.3.20. Sanofi Aventis 17.3.21. Sanquin 17.3.22. Sterinova 17.3.23. Sun Pharmaceuticals 18. Primary Key Insights

About This Report

Report ID 36416
Category Healthcare
Published Date Nov 2019
Updated Date oct 2020
Contact Us